14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
GOTU vs UTI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
UTI Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 6–4 Matrix Metrics)
UTI Overall Winner
6-Pillar Tally: GOTU 3 – 3 UTI
Matrix Metrics: GOTU 4 – 6 UTI
As of Nov 20, 2026, Universal Technical Institute, Inc. (UTI) is the stronger overall head-to-head candidate over Gaotu Techedu Inc. (GOTU) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). GOTU carries a Unified Composite Score of 46.7/100 (HOLD) at $2.06 (N/M Forward P/E, -6.6% operating margin), whereas UTI carries 37.4/100 (SELL) at $17.17 (23.3x Forward P/E, 5.1% operating margin).
Composite vs. Pillar Nuance: While GOTU currently prints a higher short-term Unified Composite Score (46.7/100 HOLD vs. UTI 37.4/100 SELL), UTI captures the overall institutional head-to-head verdict (6–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (5.1% vs. -6.6% operating margin) and revenue trajectory (+6.0% vs. +20.2% YoY).
Technical & Structure Timing Caution: GOTU trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 32.1); meanwhile UTI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GOTU vs UTI. Trailing 12-month operating profitability (GOTU -6.6% vs UTI 5.1%) and valuation multiples (GOTU N/M vs UTI 23.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Education & Training Services value chain with $535.9M market capitalization and -6.6% operating margin.
OpEx & R&D Reinvestment74.1% of Rev ($4.91B)
90D Engineering Disclosures0 Published
UTI Moat ProfileCyclical / Execution-Driven Positioning
Education & Training Services Operator
Competes within the Education & Training Services value chain with $1.1B market capitalization and 5.1% operating margin.
OpEx & R&D Reinvestment42.5% of Rev ($381M)
90D Engineering Disclosures0 Published
Investor FAQ GOTU vs UTI Key Questions & Quantitative Answers
As of Nov 20, 2026, Universal Technical Institute, Inc. (UTI) is the stronger overall head-to-head candidate over Gaotu Techedu Inc. (GOTU) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). GOTU carries a Unified Composite Score of 46.7/100 (HOLD) at $2.06 (N/M Forward P/E, -6.6% operating margin), whereas UTI carries 37.4/100 (SELL) at $17.17 (23.3x Forward P/E, 5.1% operating margin). Composite vs. Pillar Nuance: While GOTU currently prints a higher short-term Unified Composite Score (46.7/100 HOLD vs. UTI 37.4/100 SELL), UTI captures the overall institutional head-to-head verdict (6–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (5.1% vs. -6.6% operating margin) and revenue trajectory (+6.0% vs. +20.2% YoY). Technical & Structure Timing Caution: GOTU trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 32.1); meanwhile UTI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
GOTU leads the Growth & Scale pillar: GOTU posts +20.2% YoY revenue growth and -71.2% YoY earnings growth on $6.62B TTM revenue (67.5% gross margin, -6.6% operating margin), compared with UTI at +6.0% YoY revenue growth and -3.3% YoY earnings growth on $897M TTM revenue (47.6% gross margin, 5.1% operating margin). On trailing 12-month operating scale, GOTU generates $6.62B in USD-normalized revenue versus $897M for UTI. In operating R&D and SG&A reinvestment, GOTU deploys 74.1% of Rev ($4.91B) (0 90-day corporate R&D disclosures) versus 42.5% of Rev ($381M) (0 disclosures) for UTI.
UTI screens cheaper on headline valuation multiples. GOTU trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-4.6% EBITDA margin), whereas UTI trades at 23.3x Forward P/E, 33.1x Trailing P/E, 1.96x PEG, and 1.2x EV/Revenue (9.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GOTU (-25.1% ROE) versus UTI (9.7% ROE) capital efficiency.
In options market volatility and institutional positioning, GOTU carries 95.6% implied volatility (100th %ile, Extreme (>80th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.81β · 57% Vol realized risk). By comparison, UTI carries 65.9% implied volatility (10th %ile, Compressed (<25th %ile)), a 1.09x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.22β · 83% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.